nct_id,nlm_download_date_description,study_first_submitted_date,results_first_submitted_date,disposition_first_submitted_date,last_update_submitted_date,study_first_submitted_qc_date,study_first_posted_date,study_first_posted_date_type,results_first_submitted_qc_date,results_first_posted_date,results_first_posted_date_type,disposition_first_submitted_qc_date,disposition_first_posted_date,disposition_first_posted_date_type,last_update_submitted_qc_date,last_update_posted_date,last_update_posted_date_type,start_month_year,start_date_type,start_date,verification_month_year,verification_date,completion_month_year,completion_date_type,completion_date,primary_completion_month_year,primary_completion_date_type,primary_completion_date,target_duration,study_type,acronym,baseline_population,brief_title,official_title,overall_status,last_known_status,phase,enrollment,enrollment_type,source,limitations_and_caveats,number_of_arms,number_of_groups,why_stopped,has_expanded_access,expanded_access_type_individual,expanded_access_type_intermediate,expanded_access_type_treatment,has_dmc,is_fda_regulated_drug,is_fda_regulated_device,is_unapproved_device,is_ppsd,is_us_export,biospec_retention,biospec_description,ipd_time_frame,ipd_access_criteria,ipd_url,plan_to_share_ipd,plan_to_share_ipd_description,created_at,updated_at,intervention_type,intervention_name,description,intervention_count,status,facility_name,city,state,zip,country,site_count
NCT04308187,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-12,NA,NA,2020-03-12,2020-03-12,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-12,2020-03-13,Actual,"March 11, 2020",Anticipated,2020-03-11,March 2020,2020-03-31,March 2022,Anticipated,2022-03-31,March 2022,Anticipated,2022-03-31,1 Day,Observational [Patient Registry],COVISTRESS,,Influence of the COvid-19 Epidemic on STRESS,The COVISTRESS Study: Influence of the COvid-19 Epidemic on STRESS,Not yet recruiting,NA,NA,50000,Anticipated,"University Hospital, Clermont-Ferrand",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:20:07Z,2020-04-01T09:20:07Z,NA,NA,NA,NA,,"University Hospital, Clermont-Ferrand",Clermont-Ferrand,,63000,France,1
NCT04314271,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-16,NA,NA,2020-03-16,2020-03-16,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-16,2020-03-19,Actual,"March 20, 2020",Anticipated,2020-03-20,March 2020,2020-03-31,"May 31, 2020",Anticipated,2020-05-31,"May 1, 2020",Anticipated,2020-05-01,3 Weeks,Observational [Patient Registry],NA,,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Recruiting,NA,NA,80,Anticipated,Xiangya Hospital of Central South University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:19:19Z,2020-04-01T09:19:19Z,NA,NA,NA,NA,Recruiting,"Xiangya Hospital, Central South University",Changsha,Hunan,410000,China,1
NCT04318314,"ClinicalTrials.gov processed this data on April 03, 2020",2020-03-17,NA,NA,2020-03-25,2020-03-19,2020-03-23,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-26,Actual,"March 18, 2020",Actual,2020-03-18,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2020",Anticipated,2020-12-31,6 Months,Observational [Patient Registry],COVID19-HCW,,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Recruiting,NA,NA,400,Anticipated,"University College, London",,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood samples Nasal and oropharygeal swabs
    ",NA,NA,NA,Yes,Publication of results in open access journals; sharing of results in scientific databases.,2020-04-05T09:05:57Z,2020-04-05T09:05:57Z,Diagnostic Test,COPAN swabbing and blood sample collection,COPAN swabbing of nostrils and/or oropharynx and blood sample collection,1,"Recruiting|Active, not recruiting",Barts Heart Center|Royal Free London NHS Foundation Trust,London|London,|,|,United Kingdom|United Kingdom,2
NCT04315870,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-18,NA,NA,2020-03-19,2020-03-19,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-19,2020-03-20,Actual,"January 1, 2020",Actual,2020-01-01,March 2020,2020-03-31,"April 30, 2020",Anticipated,2020-04-30,"April 20, 2020",Anticipated,2020-04-20,3 Months,Observational [Patient Registry],I-COVID,,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy,Recruiting,NA,NA,20,Anticipated,Federico II University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not decided yet,2020-04-01T09:19:07Z,2020-04-01T09:19:07Z,Other,pregnant women with laboratory-confirmed 2019-n-CoV,Clinical records and compiled data of all consecutive hospitalized and outpatient pregnant women with laboratory-confirmed 2019-n-CoV were included in a merged database,1,Recruiting,University of Naples Federico II,Napoli,,80100,Italy,1
NCT04319016,"ClinicalTrials.gov processed this data on April 29, 2020",2020-03-20,NA,NA,2020-04-25,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-25,2020-04-28,Actual,"January 1, 2020",Actual,2020-01-01,April 2020,2020-04-30,"May 1, 2020",Anticipated,2020-05-01,"April 30, 2020",Anticipated,2020-04-30,3 Months,Observational [Patient Registry],COVID-preg,,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Recruiting,NA,NA,200,Anticipated,Federico II University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not planned yet,2020-04-30T09:18:49Z,2020-04-30T09:18:49Z,Other,pregnant women with laboratory-confirmed 2019-n-CoV,Clinical records and compiled data of all consecutive hospitalized and outpatient pregnant women with laboratory-confirmed 2019-n-CoV were included in a merged database,1,Recruiting,Gabriele Saccone,Napoli,,80129,Italy,1
NCT04320472,"ClinicalTrials.gov processed this data on April 29, 2020",2020-03-22,NA,NA,2020-04-22,2020-03-22,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"March 23, 2020",Actual,2020-03-23,April 2020,2020-04-30,December 2020,Anticipated,2020-12-31,December 2020,Anticipated,2020-12-31,3 Months,Observational [Patient Registry],NeuroCOVID19,,Acute Encephalopathy in Critically Ill Patients With COVID-19,Outcomes in Patients With Acute Encephalopathy and SARS-Cov-2 Infection,Recruiting,NA,NA,250,Anticipated,Ictal Group,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:18:46Z,2020-04-30T09:18:46Z,Other,Follow up,"Follow up up to day 90 (Glasgow outcome scale, functionnal impairments)",1,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Jackson Memorial Health System; University of Miami, Miller School of Medicine|Centre Hospitalier d'Argenteuil|Centre Hospitalier de Beauvais|Centre Hospitalier Universitaire Ambroise ParÃ©|Centre Hospitalier de Bourg en Bresse|Centre Hospitalier RÃ©gional Universitaire de Brest|Centre Hospitalier de Brives|Centre Hospitalier Universitaire Beaujon|Centre Hospitalier Universitaire Louis Mourier|Centre Hospitalier Universitaire Henri Mondor|Centre hospitalier de Dieppe|Centre Hospitalier Universitaire de Dijon|Centre Hospitalier d'Etampes|Grand HÃ´pital de l'Est Francilien - Site de Marne-la-VallÃ©e|Centre Hospitalier de la Roche-sur-Yon|Centre Hospitalier de La Rochelle|Centre Hospitalier de Versailles|Centre Hospitalier Universitaire de Lille|Centre Hospitalier Universitaire HÃ´pital Edouard Herriot|HÃ´pital privÃ© Jacques Cartier|Groupe Hospitalier Sud Ile-de-France|Centre Hospitalier Universitaire de Nantes|Centre Hospitalier RÃ©gional d'OrlÃ©ans|Centre Hospitalier Universitaire Cochin|Groupe hospitalier Paris Saint-Joseph|HÃ´pital Fondation Adolphe de Rothschild|Hopital PrivÃ© Claude Galien|Centre Hospitalier Universitaire de Rennes|Centre Hospitalier de Roanne|Hopital Foch|Centre Hospitalier de Toulon|Centre Hospitalier Universitaire de Toulouse|Centre Hospitalier Universitaire de Tours|Gustave-Roussy|Hospital Clinic Universitari",Miami|Argenteuil|Beauvais|Boulogne|Bourg-en-Bresse|Brest|Brive-la-Gaillarde|Clichy|Colombes|CrÃ©teil|Dieppe|Dijon|Etampes|Jossigny|La Roche-sur-Yon|La Rochelle|Le Chesnay|Lille|Lyon|Massy|Melun|Nantes|OrlÃ©ans|Paris|Paris|Paris|Quincy-sous-SÃ©nart|Rennes|Roanne|Suresnes|Toulon|Toulouse|Tours|Villejuif|Valencia,Florida||||||||||||||||||||||||||||||||||,33136||||||||||||||||78150||||||||||||||||||,United States|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|Spain,35
NCT04321811,"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-23,NA,NA,2020-03-30,2020-03-24,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-02,Actual,"March 21, 2020",Actual,2020-03-21,March 2020,2020-03-31,"March 20, 2022",Anticipated,2022-03-20,"March 20, 2021",Anticipated,2021-03-20,1 Year,Observational [Patient Registry],BEAT19,,"Behavior, Environment And Treatments for Covid-19",A PATIENT-CENTRIC OUTCOMES REGISTRY OF PATIENTS WITH KNOWN OR SUSPECTED NOVEL CORONAVIRUS INFECTION SARS-COV-2 (COVID-19),Recruiting,NA,NA,100000,Anticipated,xCures,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,De-identified datasets will be made available to qualified researchers in accordance with the study protocol.,2020-04-12T09:08:04Z,2020-04-12T09:08:04Z,Other,"Observation of patients with known, suspected, or at risk for COVID-19 infection",Participants will receive daily diary surveys to track the symptomatic course of known or suspected COVID-19 patients as well as use of any interventions or treatments.,1,Recruiting,BEAT19.org,San Francisco,California,94022,United States,1
NCT04323839,"ClinicalTrials.gov processed this data on April 29, 2020",2020-03-24,NA,NA,2020-04-22,2020-03-24,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"March 31, 2024",Anticipated,2024-03-31,"March 31, 2024",Anticipated,2024-03-31,12 Months,Observational [Patient Registry],PRIORITY,,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),PRIORITY (Pregnancy Coronavirus Outcomes Registry),Recruiting,NA,NA,2000,Anticipated,"University of California, San Francisco",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:18:34Z,2020-04-30T09:18:34Z,Other|Other,Pregnant women under investigation for Coronavirus or diagnosed with COVID-19|Postpartum women under investigation for Coronavirus or diagnosed with COVID-19,This is an observational study with no intervention|This is an observational study with no intervention,2,Recruiting,"University of California, San Francisco",San Francisco,California,94143,United States,1
NCT04325412,"ClinicalTrials.gov processed this data on April 03, 2020",2020-03-25,NA,NA,2020-03-25,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,"June 23, 2021",Anticipated,2021-06-23,"March 23, 2021",Anticipated,2021-03-23,30 Days,Observational [Patient Registry],CAPACITY-COVID,,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Recruiting,NA,NA,1000,Anticipated,UMC Utrecht,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-06T08:54:50Z,2020-04-06T08:54:50Z,NA,NA,NA,NA,Recruiting,University Medical Center Utrecht,Utrecht,,3584 CX,Netherlands,1
NCT04327479,"ClinicalTrials.gov processed this data on April 29, 2020",2020-03-26,NA,NA,2020-04-24,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-04-24,2020-04-27,Actual,"March 26, 2020",Actual,2020-03-26,April 2020,2020-04-30,"March 25, 2026",Anticipated,2026-03-25,"March 25, 2026",Anticipated,2026-03-25,1 Year,Observational [Patient Registry],NA,,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Recruiting,NA,NA,728,Anticipated,"University Hospital, Essen",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Will be made available upon request,2020-04-30T09:18:26Z,2020-04-30T09:18:26Z,Diagnostic Test,Assessment of cardiovascular diseases and cardiovascular risk factors,"At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.",1,Recruiting,University Hospital Essen,Essen,NRW,45147,Germany,1
NCT04327674,"ClinicalTrials.gov processed this data on April 09, 2020",2020-03-27,NA,NA,2020-03-30,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 14, 2020",Actual,2020-03-14,March 2020,2020-03-31,"May 15, 2020",Anticipated,2020-05-15,"May 15, 2020",Anticipated,2020-05-15,1 Month,Observational [Patient Registry],NA,,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Recruiting,NA,NA,375,Anticipated,University of Aarhus,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-10T09:15:41Z,2020-04-10T09:15:41Z,NA,NA,NA,NA,Recruiting|Recruiting,Lungemedicinsk Forskningsafdeling. Aarhus University Hospital|Regionshospitalet Horsens.,Aarhus|Horsens,|,8000|,Denmark|Denmark,2
NCT04329559,"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-29,NA,NA,2020-03-29,2020-03-29,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-29,2020-04-01,Actual,"March 30, 2020",Actual,2020-03-30,March 2020,2020-03-31,"June 29, 2021",Anticipated,2021-06-29,"June 29, 2020",Anticipated,2020-06-29,1 Year,Observational [Patient Registry],NA,,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,NA,NA,50,Anticipated,Hepatopancreatobiliary Surgery Institute of Gansu Province,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-11T09:13:03Z,2020-04-11T09:13:03Z,NA,NA,NA,NA,Not yet recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Not yet recruiting|Recruiting|Recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Recruiting|Recruiting,"Dalian Sixth People's Hospital|Minda Hospital Affiliated to Hubei University for Nationalities|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture|The First Hospital of Lanzhou University|The Central Hospital of Lishui City|Guangxi Zhuang Autonomous Region|The Sixth Peoples Hospital of Shenyang|Shenzhen Third People's Hospital|Suizhou Hospital, Hubei University of Medicine|Tianjin Second People's Hospital|Ankang Central Hospital|Renmin Hospital of Wuhan University|Wuhan Union Hospital|Xingtai People's Hospital|The Affiliated Third Hospital of Jiangsu University",Dalian|Enshi|Enshi|Lanzhou|Lishui|Nanning|Shenyang|Shenzhen|Suizhou|Tianjin|Wuhan|Wuhan|Wuhan|Xingtai|Zhenjiang,||||||||||||||,||||||||||||||,China|China|China|China|China|China|China|China|China|China|China|China|China|China|China,15
NCT04331574,"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-30,NA,NA,2020-04-01,2020-04-01,2020-04-02,Actual,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-02,Actual,"March 10, 2020",Actual,2020-03-10,April 2020,2020-04-30,"April 30, 2020",Anticipated,2020-04-30,"April 10, 2020",Anticipated,2020-04-10,3 Months,Observational [Patient Registry],SARS-RAS,,Renin-Angiotensin System Inhibitors and COVID-19,Phase IV Observational Study to Associate Hypertension and Hypertensinon Treatment to COVID19,Recruiting,NA,NA,2000,Anticipated,Societa Italiana dell'Ipertensione Arteriosa,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-12T09:06:31Z,2020-04-12T09:06:31Z,NA,NA,NA,NA,Recruiting,Spedali Civili di Brescia,Brescia,,,Italy,1
NCT04331171,"ClinicalTrials.gov processed this data on April 24, 2020",2020-03-30,NA,NA,2020-04-16,2020-03-30,2020-04-02,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-17,Actual,"March 17, 2020",Actual,2020-03-17,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"March 31, 2020",Actual,2020-03-31,1 Day,Observational [Patient Registry],COVID CALL 15,,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Recruiting,NA,NA,3000000,Anticipated,Weprom,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-27T09:01:09Z,2020-04-27T09:01:09Z,Device,Web application users,questionnaire of comorbidity and symptoms completed by the patient on his smartphone,1,Recruiting,All French Emergency services,Le Mans,,,France,1
NCT04331860,"ClinicalTrials.gov processed this data on April 03, 2020",2020-03-30,NA,NA,2020-03-31,2020-03-31,2020-04-02,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-02,Actual,"March 30, 2020",Actual,2020-03-30,March 2020,2020-03-31,"March 30, 2025",Anticipated,2025-03-30,"March 30, 2025",Anticipated,2025-03-30,5 Years,Observational [Patient Registry],C19REG,,COVID-19 Public Image Registry,COVID-19 Public Image Registry,Recruiting,NA,NA,500000,Anticipated,RAD-AID International,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"All data will be shared, but in a de-identified state.",2020-04-06T08:51:02Z,2020-04-06T08:51:02Z,Other,No intervention,"There is no intervention, this is an observational registry",1,Recruiting,To be determined,San Francisco,California,94960,United States,1
NCT04336956,"ClinicalTrials.gov processed this data on April 29, 2020",2020-03-30,NA,NA,2020-04-19,2020-04-06,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-19,2020-04-21,Actual,"April 7, 2020",Actual,2020-04-07,April 2020,2020-04-30,"June 30, 2021",Anticipated,2021-06-30,"June 30, 2021",Anticipated,2021-06-30,6 Months,Observational [Patient Registry],PANDOR,,Covid-19 Pediatric Observatory,Covid-19 Pediatric Observatory,Recruiting,NA,NA,250,Anticipated,Centre Hospitalier Intercommunal Creteil,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:17:48Z,2020-04-30T09:17:48Z,Other,hospitalized children with Covid19,All patients under 18 years hospitalized with a covid19 diagnosis,1,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,Chu Felix Guyon|Ch St Esprit|Ch General Aix En Provence -|CHU Angers|CH d'ANGOULEME|Pringy - Ch D'Annecy|Ch Armentieres|CH Arpajon|Ch Auxerre|CH GENERAL Henri Duffaut|CHU de BESANCON|Hopital Femme Enfant|Ch de Pontoise|Ch W. Morey|CH de CHAMBERY|Ch Hotel Dieu|Centre Hospitalier intercommunal de Creteil|Ch de Dax|Hopital D'Enfants Chu Dijon|CH Louviers Val de Reuil|CH Gonesse|CH d'HYERES|Ch de Marne La Vallee|Chru de Grenoble|CHGÃ©nÃ©ral du HAVRE|Hopital Saint Vincent de Paul|Ch de Longjumeau|Hopital Femme Mere Enfant-Bron|Hopital Nord Enfants|Hopital de Meaux|CH de Montargis|CH de MONTBRISON|CHRU de Nancy|Nantes - Hopital Mere Enfant|Ch de Neuilly Sur Seine|Hopital Lenval|Assistance Publique HÃ´pitaux de Paris|POISSY - CH de POISSY|QUIMPER - CH de Cornouaille|RANG du FLIERS - C.H.A.M.|Hopital AmÃ©ricain CHU REIMS|CH RODEZ|Chu Rouen|Hopital Charles-Nicolle|Chu St Etienne|Ch de Saint Malo|Ch Du Pays Du Mont Blanc|Chg Salon de Provence|CH Bel Air|Hopital Sainte Musse|CHU Toulouse-hÃ´pital des Enfants|CH de TROYES|Ch Le Chesnay,Saint Denis|Agen|Aix-en-Provence|Angers|AngoulÃ¨me|Annecy|ArmentiÃ¨res|Arpajon|Auxerre|Avignon|BesanÃ§on|Caen|Cergy-Pontoise|Chalon-sur-SaÃ´ne|ChambÃ©ry|Chartres|Creteil|Dax|Dijon|Elbeuf|Gonesse|HyÃ¨res|Jossigny|La Tronche|Le Havre|Lille|Longjumeau|Lyon|Marseille|Meaux|Montargis|Montbrison|Nancy|Nantes|Neuilly-sur-Seine|Nice|Paris|Poissy|Quimper|RANG du FLIERS|Reims|Rodez|Rouen|Rouen|Saint Etienne|Saint-Malo|Sallanches|Salon de Provence|Thionville|Toulon|Toulouse|Troyes|Versailles,La RÃ©union||||||||||||||||||||||||||||||||||||||||||||||||||||,||||||||||||||||94010||||||||||||||||||||75004||||||||||||||||,France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France,53
NCT04333693,"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-31,NA,NA,2020-04-02,2020-04-02,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-02,2020-04-03,Actual,"April 1, 2020",Anticipated,2020-04-01,March 2020,2020-03-31,"November 1, 2020",Anticipated,2020-11-01,"October 1, 2020",Anticipated,2020-10-01,6 Months,Observational [Patient Registry],Covid-VAS,,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study (Covid-VAS),Not yet recruiting,NA,NA,50,Anticipated,Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,No sharing plan available nowadays.,2020-04-13T08:59:15Z,2020-04-13T08:59:15Z,Procedure,Vascular surgery,"Open vascular, endovascular or hybrid procedures",1,,Spanish Society for Angiology and Vascular Surgery,Madrid,,28006,Spain,1
NCT04333953,"ClinicalTrials.gov processed this data on April 16, 2020",2020-03-31,NA,NA,2020-04-04,2020-04-01,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-04,2020-04-07,Actual,"April 1, 2020",Anticipated,2020-04-01,April 2020,2020-04-30,"October 1, 2020",Anticipated,2020-10-01,"October 1, 2020",Anticipated,2020-10-01,1 Month,Observational [Patient Registry],NA,,COVID-19 in Patients With HIV,Prospective Observational Study for Patients With HIV and Confirmed SARS-CoV-2,Recruiting,NA,NA,500,Anticipated,University of Missouri-Columbia,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-17T09:13:21Z,2020-04-17T09:13:21Z,Other,No intervention,"No intervention, observational study",1,Recruiting,University of Missouri-Columbia,Columbia,Missouri,65212,United States,1
NCT04333875,"ClinicalTrials.gov processed this data on April 16, 2020",2020-04-01,NA,NA,2020-04-03,2020-04-01,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-03,2020-04-07,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,December 2020,Anticipated,2020-12-31,December 2020,Anticipated,2020-12-31,6 Months,Observational [Patient Registry],AS DEFER,,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis - a Collateral Effect of the SARS-CoV-2 Pandemic (AS DEFER),Recruiting,NA,NA,100,Anticipated,"University Hospital Inselspital, Berne",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-17T09:13:22Z,2020-04-17T09:13:22Z,Device,TAVR or SAVR,Patients with critical aortic stenosis as defined by an AVA <0.6 cm2 or a transvalvular mean gradient of >60 mmHg or a history of cardiac decompensation during the previous 3 months or clinical symptoms on minimal exertion (NYHA III) will be allocated to TAVR or SAVR.,1,Recruiting,"Department of Cardiology, Bern University Hospital",Bern,,3010,Switzerland,1
NCT04334291,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-01,NA,NA,2020-04-25,2020-04-03,2020-04-06,Actual,NA,NA,NA,NA,NA,NA,2020-04-25,2020-04-28,Actual,"March 23, 2020",Actual,2020-03-23,April 2020,2020-04-30,"May 5, 2020",Anticipated,2020-05-05,"May 1, 2020",Anticipated,2020-05-01,2 Weeks,Observational [Patient Registry],HOPE COVID 19,,"International COVID19 Clinical Evaluation Registry,",International COVID19 Clinical Evaluation Registry: HOPECOVID19. (Health Outcome Predictive Evaluation for COVID19),Recruiting,NA,NA,6000,Anticipated,"St Carlos Hospital, Madrid, Spain",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,IPD are to be share among HOPE researchers.,2020-04-30T09:18:00Z,2020-04-30T09:18:00Z,Combination Product,Observational (registry),Observational study.,1,Recruiting,Hospital Lclinico San Carlos,Madrid,,28040,Spain,1
NCT04341766,"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-01,NA,NA,2020-04-09,2020-04-09,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"March 31, 2020",Actual,2020-03-31,April 2020,2020-04-30,"September 30, 2020",Anticipated,2020-09-30,"May 1, 2020",Anticipated,2020-05-01,6 Weeks,Observational [Patient Registry],NA,,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Prospective Descriptive Study on the Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid19,Recruiting,NA,NA,200,Anticipated,Centre Hospitalier Intercommunal Creteil,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-20T08:49:52Z,2020-04-20T08:49:52Z,Other,No special intervention,No special intervention : Ultrasound data will be collected,1,Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting,CHG de Chambery|Centre Hospitalier Intercommunal de CrÃ©teil|CHU de Limoges|APHM - Hopital Nord|CHU de Nancy|Hopital privÃ© de la Loire|CHU de Tours,ChambÃ©ry|CrÃ©teil|Limoges|Marseille|Nancy|Saint-Ã‰tienne|Tours,||||||,73000|94000|87000|13015|54035|42100|37000,France|France|France|France|France|France|France,7
NCT04336345,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-02,NA,NA,2020-04-22,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"May 30, 2020",Anticipated,2020-05-30,"April 30, 2020",Anticipated,2020-04-30,1 Month,Observational [Patient Registry],MexCOVID-19,,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Outcomes of Patients With COVID-19 in the Intensive Care Unit: A National Observational Study (Mexico COVID-19 ICU Study),Recruiting,NA,NA,150,Anticipated,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,All IPD that underlie could results in a publication.,2020-04-30T09:17:52Z,2020-04-30T09:17:52Z,NA,NA,NA,NA,Recruiting|Recruiting,Instituto Nacional de Ciencias MÃ©dicas y NutriciÃ³n Salvador ZubirÃ¡n|All centres from Mexico willing to contribute are Welcome.,Mexico City|Mexico,|,14000|,Mexico|Mexico,2
NCT04335773,"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-03,NA,NA,2020-04-16,2020-04-03,2020-04-06,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-17,Actual,"April 3, 2020",Actual,2020-04-03,April 2020,2020-04-30,"December 31, 2030",Anticipated,2030-12-31,"December 31, 2030",Anticipated,2030-12-31,6 Months,Observational [Patient Registry],NA,,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology","COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Recruiting,NA,NA,350,Anticipated,"University Hospital, Akershus",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blodsamples, Eluate from nasopharyngeal sample, Urin, Feces,
    ",NA,NA,NA,NA,NA,2020-04-27T09:00:52Z,2020-04-27T09:00:52Z,NA,NA,NA,NA,Recruiting,Akershus universistetssykehus,LÃ¸renskog,,,Norway,1
NCT04345536,"ClinicalTrials.gov processed this data on April 22, 2020",2020-04-05,NA,NA,2020-04-12,2020-04-12,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-04-12,2020-04-14,Actual,"March 15, 2020",Actual,2020-03-15,April 2020,2020-04-30,"May 1, 2021",Anticipated,2021-05-01,"January 1, 2021",Anticipated,2021-01-01,1 Year,Observational [Patient Registry],CovidRegOUH,,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Recruiting,NA,NA,400,Anticipated,Oslo University Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-24T09:05:45Z,2020-04-24T09:05:45Z,NA,NA,NA,NA,Recruiting,Oslo University Hospital,Oslo,,0424,Norway,1
NCT04337346,"ClinicalTrials.gov processed this data on April 16, 2020",2020-04-05,NA,NA,2020-04-06,2020-04-06,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-07,Actual,"April 5, 2020",Actual,2020-04-05,April 2020,2020-04-30,"April 25, 2020",Anticipated,2020-04-25,"April 20, 2020",Anticipated,2020-04-20,20 Days,Observational [Patient Registry],NA,,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Endometriosis Patients Covid 19 Anxiety,"Active, not recruiting",NA,NA,80,Anticipated,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-17T09:12:07Z,2020-04-17T09:12:07Z,NA,NA,NA,NA,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04337320,"ClinicalTrials.gov processed this data on April 16, 2020",2020-04-05,NA,NA,2020-04-06,2020-04-06,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-07,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"June 20, 2020",Anticipated,2020-06-20,"June 15, 2020",Anticipated,2020-06-15,2 Months,Observational [Patient Registry],NA,,Evaluation of Postnatal Outcomes of Covid 19 Positive Mothers Newborns,Postnatal Outcomes of Covid 19 Positive Mothers Newborns,"Active, not recruiting",NA,NA,70,Anticipated,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-17T09:12:08Z,2020-04-17T09:12:08Z,Other,newborns from covid 19 positive mothers,"Evaluation of apgar, hemogram and developmental status of babies born from covid 19 positive mothers",1,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04337866,"ClinicalTrials.gov processed this data on April 09, 2020",2020-04-05,NA,NA,2020-04-07,2020-04-06,2020-04-08,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-09,Estimate,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"May 30, 2020",Anticipated,2020-05-30,"May 28, 2020",Anticipated,2020-05-28,2 Months,Observational [Patient Registry],NA,,Evaluation of the Effects of Ozone Therapy on Covid 19 Positive Patients,Ozone Therapy on Covid 19 Positive Patients,"Active, not recruiting",NA,NA,50,Anticipated,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-04-10T09:09:33Z,2020-04-10T09:09:33Z,Other,ozone therapy group (covid positive),The effects of ozone therapy given in addition to the treatment they received in covid 19 positive patients (hydroxychloroquine + azithromycin),1,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04337294,"ClinicalTrials.gov processed this data on April 09, 2020",2020-04-05,NA,NA,2020-04-07,2020-04-05,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-09,Estimate,"March 21, 2020",Actual,2020-03-21,April 2020,2020-04-30,"May 22, 2020",Anticipated,2020-05-22,"May 20, 2020",Anticipated,2020-05-20,2 Months,Observational [Patient Registry],NA,,Evaluation of Blood Results of Covid 19 Positive Pregnants,Blood Results of Covid 19 Positive Pregnants,"Active, not recruiting",NA,NA,100,Anticipated,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      peripheral blood values; hemogram, biochemistry (ast- sub-urea, creatinine, potassium,
      sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)
    ",NA,NA,NA,Yes,NA,2020-04-10T09:09:53Z,2020-04-10T09:09:53Z,Biological,Evaluation of blood results of covid 19 positive pregnant patients,"peripheral blood values; hemogram, biochemistry (ast- sub-urea, creatinine, potassium, sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)",1,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04337281,"ClinicalTrials.gov processed this data on April 09, 2020",2020-04-05,NA,NA,2020-04-05,2020-04-05,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-05,2020-04-07,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"May 30, 2020",Anticipated,2020-05-30,"May 28, 2020",Anticipated,2020-05-28,2 Months,Observational [Patient Registry],NA,,Evaluation of the Effect of High-dose Vitamin C Use in Covid 19 Positive Pregnants,High-dose Vitamin C Use in Covid 19 Positive Pregnants,"Active, not recruiting",NA,NA,50,Anticipated,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      (hemogram, biochemistry (ast- urea, creatinine, potassium, sodium, calcium, magnesium,
      vitamin d, homocysteine, ggt, crp)
    ",NA,NA,NA,Yes,NA,2020-04-10T09:09:53Z,2020-04-10T09:09:53Z,Drug,High dose vitamin C,researchers will evaluate the change of peripheral blood values in pregnant women receiving high doses of vitamin C,1,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04354519,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-06,NA,NA,2020-04-20,2020-04-20,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-21,Actual,"March 14, 2020",Actual,2020-03-14,March 2020,2020-03-31,"July 14, 2022",Anticipated,2022-07-14,"July 14, 2021",Anticipated,2021-07-14,1 Year,Observational [Patient Registry],UKMSRCV19,,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,The UK MS Regsiter COVID-19 Substudy,Recruiting,NA,NA,3000,Anticipated,Swansea University,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Aggregate results will be published Line level data avaialble to other Researchers subject to Governance approval within Secure e-Research Platform,2020-04-30T09:14:50Z,2020-04-30T09:14:50Z,NA,NA,NA,NA,Recruiting,Swansea Univeristy,Swansea,,SA28PP,United Kingdom,1
NCT04353583,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-06,NA,NA,2020-04-21,2020-04-17,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,July 2020,Anticipated,2020-07-31,July 2020,Anticipated,2020-07-31,3 Months,Observational [Patient Registry],NA,,Renal Outcome in Patients With COVID-19,Renal Outcome in Patients With Coronavirus Disease 2019 (COVID-19),Not yet recruiting,NA,NA,40,Anticipated,University of Giessen,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:15:27Z,2020-04-30T09:15:27Z,NA,NA,NA,NA,,"University Hospital Giessen and Marburg, Giessen",Giessen,Hessen,35382,Germany,1
NCT04340479,"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-06,NA,NA,2020-04-08,2020-04-06,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-08,2020-04-10,Actual,"May 1, 2020",Anticipated,2020-05-01,April 2020,2020-04-30,"May 1, 2021",Anticipated,2021-05-01,"May 1, 2021",Anticipated,2021-05-01,12 Months,Observational [Patient Registry],NA,,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Not yet recruiting,NA,NA,20,Anticipated,"University of Colorado, Denver",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-20T08:50:35Z,2020-04-20T08:50:35Z,Diagnostic Test,Ultrasound lung imaging as part of FAST+ evaluation,"FAST+ evaluations will expand on the traditional FAST exam to systematically survey bilateral lung fields. Traditional FAST evaluation will survey the perihepatic, perisplenic, pelvic, and pericardial areas. Representative images will be saved by the performing provider for further evaluation. Up to sixteen areas in total will be included in FAST+ evaluation:
Anterior midclavicular right and left (apical, medial, basal)
Posterior paraspinal right and left* (apical, medial, basal)
*Posterior lung evaluation will be omitted if patients are at risk for further traumatic injury from repeated side rolling.
Lateral axillary medial right and left (apical and basal)
Specifically, we will document the presence or absence of bilateral, diffuse pleural line abnormalities, subpleural consolidations, white lung areas and thick, irregular vertical artifacts in these lung fields by ultrasound and will record these findings.",1,,Children's Hospital Colorado,Aurora,Colorado,80045,United States,1
NCT04340466,"ClinicalTrials.gov processed this data on April 22, 2020",2020-04-07,NA,NA,2020-04-10,2020-04-07,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"April 3, 2020",Actual,2020-04-03,April 2020,2020-04-30,"April 30, 2021",Anticipated,2021-04-30,"June 30, 2020",Anticipated,2020-06-30,28 Days,Observational [Patient Registry],FRENCH CORONA,,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study,Recruiting,NA,NA,220,Anticipated,Centre Hospitalier Universitaire de NÄ«mes,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-24T09:07:27Z,2020-04-24T09:07:27Z,Other,No intervention,No intervention,1,Recruiting,CHU Nimes,NÃ®mes,,30029,France,1
NCT04339556,"ClinicalTrials.gov processed this data on April 09, 2020",2020-04-07,NA,NA,2020-04-07,2020-04-07,2020-04-09,Estimate,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-09,Estimate,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"May 3, 2020",Anticipated,2020-05-03,"May 1, 2020",Anticipated,2020-05-01,45 Days,Observational [Patient Registry],NA,,Evaluation of Serum Zinc Levels Response to Treatment of Covid 19 Positive Patients,Zinc Levels in Covid-19 Positive Patients,"Active, not recruiting",NA,NA,25,Anticipated,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      serum zinc level will be measured in peripheral blood.
    ",NA,NA,NA,Yes,NA,2020-04-10T09:08:30Z,2020-04-10T09:08:30Z,Other,Zinc levels,"Since covid 19 and zinc act on the same receptor in the body, the effect of serum levels of patients on the course of the disease and response to treatment is examined.",1,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04344249,"ClinicalTrials.gov processed this data on April 22, 2020",2020-04-08,NA,NA,2020-04-10,2020-04-10,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"April 15, 2020",Anticipated,2020-04-15,April 2020,2020-04-30,"September 1, 2021",Anticipated,2021-09-01,"September 30, 2020",Anticipated,2020-09-30,6 Months,Observational [Patient Registry],IBD-COVID-19,,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Prospective Multicenter Cohort of Patients With Inflammatory Bowel Disease Treated by Infliximab or Vedolizumab During COVID-19 Pandemic,Not yet recruiting,NA,NA,850,Anticipated,Nantes University Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood
    ",NA,NA,NA,NA,NA,2020-04-24T09:06:34Z,2020-04-24T09:06:34Z,NA,NA,NA,NA,,Chu Nantes,Nantes,,,France,1
NCT04358042,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-08,NA,NA,2020-04-20,2020-04-20,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-22,Actual,"April 25, 2020",Anticipated,2020-04-25,April 2020,2020-04-30,"January 1, 2023",Anticipated,2023-01-01,"January 1, 2022",Anticipated,2022-01-01,6 Weeks,Observational [Patient Registry],PSYCHIC,,PSYCHIATRIC Disorders and Covid-19,"PSYCHIatric Disorders and Covid-19 (PSYCHIC) : Observatory of the Psychiatric, Somatic and Pharmacological Impacts of the COVID-19 Pandemic on Patients Hospitalized for Psychiatric Disorders and Suspected to be Infected by COVID-19",Not yet recruiting,NA,NA,250,Anticipated,Nantes University Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,None Retained,"
      Blood
    ",NA,NA,NA,NA,NA,2020-04-30T09:12:48Z,2020-04-30T09:12:48Z,Other|Other|Other|Other,"Brief Psychiatric Rating Scale|Depression, Anxiety and Stress Scale|Impact of Event Scale-Revised|Connor-Davidson Resilience Scale 10 items (CD-RISC 10)","The Abbreviated Psychiatric Rating Scale is a clinical scale for measuring symptomatic change in psychiatric inpatients for various conditions. It includes an accurate and complete description of the major characteristic symptoms. It is based both on patient responses and on observations made during the interview by the clinician. The usual reference period is the last two weeks.|evaluation of 3 dimensions of psychological distress: depression, anxiety and stress. The scale consists of 21 items and the patient is instructed to choose for each item the one that best corresponds to his or her experience over the past week, on a scale of 0 (""does not apply to me at all"") to 3 (""applies entirely to me, or the vast majority of the time""). A score is calculated for each dimension according to a predefined rating.|is a 22-item self-questionnaire that measures perceived stress in reference to a traumatic event during the previous 7 days. Each item is rated on a scale ranging from 0 (not at all) to 4 (extremely) and 3 sub-scores of post-traumatic symptoms are calculated: Revivification, Avoidance, Psychophysiological Activation, as well as a total score of severity of the state of stress. Acute Stress Disorder (ASD) and Post-Traumatic Stress Disorder (PTSD) share the same symptoms, the former lasting between 3 days and one month, while the latter is diagnosed when symptoms persist beyond one month. Since the exposure to the stressful event will have occurred less than a month ago, this questionnaire here will help identify a state of acute stress. A total R-ESI score equal to or greater than 33 suggests a significant level of symptoms|Self-questionnaire composed of 10 items, evaluating the resilience capacities of patients. Resilience may act as a moderator against the symptoms of PTSD. This instrument uses a 5-point Likert-type response scale ranging from 0 ""Not true at all"" to 4 ""True most of the time"".",4,,Nantes University Hospital - IFAC,Nantes,,44093,France,1
NCT04343664,"ClinicalTrials.gov processed this data on April 22, 2020",2020-04-09,NA,NA,2020-04-11,2020-04-09,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-11,2020-04-14,Actual,"April 12, 2020",Anticipated,2020-04-12,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"June 30, 2020",Anticipated,2020-06-30,12 Months,Observational [Patient Registry],New,,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Not yet recruiting,NA,NA,10000,Anticipated,Dr Cipto Mangunkusumo General Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Undecided yet,2020-04-24T09:06:52Z,2020-04-24T09:06:52Z,NA,NA,NA,NA,,dr. Cipto Mangunkusumo General Hospital,Jakarta Pusat,DKI Jakarta,10430,Indonesia,1
NCT04344002,"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-09,NA,NA,2020-04-14,2020-04-09,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-04-14,2020-04-15,Actual,"May 15, 2020",Anticipated,2020-05-15,April 2020,2020-04-30,"May 15, 2022",Anticipated,2022-05-15,"May 15, 2021",Anticipated,2021-05-15,1 Month,Observational [Patient Registry],GRAVID,,LunG canceR pAtients coVId19 Disease (GRAVID),Observational Retrospective Register of Spanish Lung Cancer Patients With COVID19 Disease,Not yet recruiting,NA,NA,200,Anticipated,Spanish Lung Cancer Group,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-25T09:17:24Z,2020-04-25T09:17:24Z,NA,NA,NA,NA,|,H. Universitario QuirÃ³n Dexeus|H.U. Puerta de Hierro,Barcelona|Madrid,|,08036|28035,Spain|Spain,2
NCT04349982,"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-10,NA,NA,2020-04-14,2020-04-14,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-14,2020-04-16,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"June 30, 2020",Anticipated,2020-06-30,30 Days,Observational [Patient Registry],POINT-C,,ICU Trial in Critical Ill COVIDâ€19 Patients,Prospective Observational ICU Trial in Critical Ill COVIDâ€19 Patients (POINT-C) Cardiovascular Risk and the Effects on Myocardial Events in Critical Ill COVID-19 Patients,Recruiting,NA,NA,50,Anticipated,Medical University of Graz,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Lipid profile once at intensive care unit admission (9 ml whole blood).
    ",NA,NA,NA,Undecided,"If other researchers need the medical data of this study for their research projects, the data will be made available after consideration.",2020-04-26T09:04:17Z,2020-04-26T09:04:17Z,Diagnostic Test,"Biomarker (TropT, Myoglobin, CK, CK-MB, LDH, D-dimer, CRP, PCT)",Factorial,1,Recruiting,Medical University of Graz,Graz,Styria,,Austria,1
NCT04348227,"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-10,NA,NA,2020-04-16,2020-04-14,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-17,Actual,"January 1, 2019",Actual,2019-01-01,April 2020,2020-04-30,"February 4, 2021",Anticipated,2021-02-04,"January 1, 2020",Actual,2020-01-01,2 Years,Observational [Patient Registry],NA,,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,"Active, not recruiting",NA,NA,120,Anticipated,HÃ´pital Universitaire Fattouma Bourguiba,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Endotracheal aspirates
    ",NA,NA,NA,Undecided,NA,2020-04-27T08:59:45Z,2020-04-27T08:59:45Z,Behavioral,Enhanced hygiene measures,"Wether or not hygiene measures dictated by the pandemic of severe acute respiratory syndrome coronavirus 19 , reduce multi drug resistant pathogens isolated in endotracheal aspirates.",1,,"Department of anesthesia and intensive care, Fattouma Bourguiba Hospital",Monastir,,5000,Tunisia,1
NCT04344912,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-10,NA,NA,2020-04-26,2020-04-10,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-04-26,2020-04-28,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,August 2020,Anticipated,2020-08-31,June 2020,Anticipated,2020-06-30,12 Months,Observational [Patient Registry],CCU-COVID19,,Impact of COVID19 Outbreak in Cardiac Acute Care,Impact of COVID19 Outbreak in Cardiac Patients Admitted in Intensive Care Unit : the CCU-COVID19 Study,Recruiting,NA,NA,500,Anticipated,Assistance Publique - HÃ´pitaux de Paris,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,The data will be available 12 months after the beginning of the Registry,to be determined,NA,Yes,Open to collaboration,2020-04-30T09:17:17Z,2020-04-30T09:17:17Z,Other,Data collection,Diagnostic and prognostic evaluation of cardiac patients hospitalized in CCU during the COVID-19 outbreak; patient's immune status regarding the presence of SARS-CoV-2 specific antibodies,1,Recruiting,"UnitÃ© de Soins Intensifs de Cardiologie, PitiÃ© SalpÃªtriÃ¨re Hospital, AP-HP",Paris,,75013,France,1
NCT04347993,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-21,2020-04-14,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"March 27, 2020",Actual,2020-03-27,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,1 Year,Observational [Patient Registry],NA,,"A Prospective ""Universal"" Observational Database for COVID-19",Real World Observational Database for COVID-19 Treatment and Outcomes,Recruiting,NA,NA,5000,Anticipated,Hackensack Meridian Health,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:16:58Z,2020-04-30T09:16:58Z,NA,NA,NA,NA,Recruiting,Hackensack Meridian Health - John Theurer Cancer Center,Hackensack,New Jersey,07601,United States,1
NCT04347798,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-16,2020-04-13,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-20,Actual,"April 15, 2020",Anticipated,2020-04-15,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,12 Months,Observational [Patient Registry],IMPACT,,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,IMPACT RAPPORT: IMPact of Antimalarials on Covid Infections: a Case Control sTudy of RAPPORT,Enrolling by invitation,NA,NA,500,Anticipated,University of Alberta,,NA,2,NA,FALSE,NA,NA,NA,FALSE,NA,NA,NA,NA,NA,Samples Without DNA,"
      Blood sample for Covid-19 serology, ABO blood type, HLA typing
    ",NA,NA,NA,NA,NA,2020-04-30T09:16:59Z,2020-04-30T09:16:59Z,Other,Hydroxychloroquine/Chloroquine,Prospective evaluation of development of Covid-19 in inflammatory arthritis patients on biologics with anti-malarials compared to inflammatory arthritis patients on biologics without anti-malarial exposure,1,,University of Alberta,Edmonton,Alberta,T6G 2G3,Canada,1
NCT04357275,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-15,NA,NA,2020-04-18,2020-04-18,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-18,2020-04-22,Actual,"March 13, 2020",Actual,2020-03-13,April 2020,2020-04-30,March 2022,Anticipated,2022-03-31,March 2021,Anticipated,2021-03-31,4 Weeks,Observational [Patient Registry],RISC-19-ICU,,The RIsk Stratification in COVID-19 Patients in the ICU Registry,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,NA,NA,10000,Anticipated,University of Zurich,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,"Each collaborator's data is available for their own use
The collaborators are encouraged to share their analysis code (the standard is R code)
Analysis on the entire registry dataset may be performed using the same analysis pathway. To request analysis on the entire dataset, a protocol may be submitted to the board
The board may make some descriptive data publicly available to support the coordination of the response to the pandemic threat
Scientific findings will be jointly published in a scientific journal according to a collaboration agreement",2020-04-30T09:13:14Z,2020-04-30T09:13:14Z,Other,ICU treatment,ICU treatment according to standard of care,1,Recruiting,University Hospital of Zurich,Zurich,,8091,Switzerland,1
NCT04353245,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-15,NA,NA,2020-04-15,2020-04-15,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-20,Actual,"June 1, 2020",Anticipated,2020-06-01,April 2020,2020-04-30,"September 30, 2021",Anticipated,2021-09-30,"September 30, 2021",Anticipated,2021-09-30,12 Months,Observational [Patient Registry],PostCOVID19,,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System: Effect of Hydroxychloroquine / Azithromycin Combined Therapy,Not yet recruiting,NA,NA,130,Anticipated,University of Sao Paulo General Hospital,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:15:38Z,2020-04-30T09:15:38Z,Other,BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM,"Organize care follow-up for patients who have had COVID-19 coronavirus infection for scientific purposes. Thus, it is expected to obtain relevant data on cardiac sequelae and pulmonary. These data are important for understanding the long-term prognosis of patients surviving this infection.",1,,Instituto do CoraÃ§Ã£o - Hospital das ClÃ­nicas - Faculdade de Medicina da Universidade de SÃ£o Paulo,SÃ£o Paulo,SP,,Brazil,1
NCT04354701,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-16,2020-04-16,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-21,Actual,"March 17, 2020",Actual,2020-03-17,April 2020,2020-04-30,December 2022,Anticipated,2022-12-31,December 2021,Anticipated,2021-12-31,12 Months,Observational [Patient Registry],CCC19,,COVID-19 and Cancer Consortium Registry,The COVID-19 and Cancer Consortium (CCC19) Registry,Recruiting,NA,NA,1000,Anticipated,Vanderbilt-Ingram Cancer Center,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:14:44Z,2020-04-30T09:14:44Z,Other,Web-based REDCap survey,"The survey takes approximately 5-10 minutes to complete and includes five parts: 1) basic demographics about the patient, including performance status and comorbidities; 2) initial COVID-19 diagnosis and clinical course; 3) cancer and cancer treatment details; 4) respondent details; 5) long-term COVID-19 outcomes.",1,Recruiting,Vanderbilt University Medical Center,Nashville,Tennessee,37232,United States,1
NCT04352764,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-23,2020-04-16,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-27,Actual,"March 27, 2020",Actual,2020-03-27,April 2020,2020-04-30,"January 31, 2021",Anticipated,2021-01-31,"December 31, 2020",Anticipated,2020-12-31,1 Month,Observational [Patient Registry],NA,,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Use of the ANTIBODY BASED LATERAL FLOW IMMUNOASSAY TESTS FOR SARSCoV-2 THAT CAUSES CORONAVIRUS DISEASE 2019 (COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Recruiting,NA,NA,5000,Anticipated,Texas Cardiac Arrhythmia Research Foundation,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,No plans decided yet,2020-04-30T09:15:54Z,2020-04-30T09:15:54Z,Diagnostic Test,CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test,The tests are being distributed under section IV.D of the current United States Food and Drug Administration (FDA) policies for diagnostic tests for coronavirus disease 2019. The test is available under an emergency access mechanism called an Emergency Use Authorization (EUA). The EUA is supported by the Secretary of Health and Human Service's (HHS's) declaration that circumstances exist to justify the emergency use of in vitro diagnostics (IVDs) for the detection and/or diagnosis of the virus that causes COVID-19,1,Recruiting,St. David's Medical Center,Austin,Texas,78705,United States,1
NCT04351529,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-17,2020-04-16,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-17,2020-04-20,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,December 2021,Anticipated,2021-12-31,December 2021,Anticipated,2021-12-31,2 Years,Observational [Patient Registry],NA,,Austrian COVID-19 Registry,Austrian COVID-19 Registry (AGMT_COVID-19),Recruiting,NA,NA,1000,Anticipated,Arbeitsgemeinschaft medikamentoese Tumortherapie,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:16:25Z,2020-04-30T09:16:25Z,NA,NA,NA,NA,Recruiting,"IIIrd Medical Department, Private Medical University Hospital Salzburg",Salzburg,,5020,Austria,1
NCT04356586,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-17,NA,NA,2020-04-21,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 30, 2020",Anticipated,2020-04-30,April 2020,2020-04-30,"July 30, 2020",Anticipated,2020-07-30,"July 30, 2020",Anticipated,2020-07-30,3 Months,Observational [Patient Registry],NA,,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Enrolling by invitation,NA,NA,300,Anticipated,Sciensano,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:13:37Z,2020-04-30T09:13:37Z,NA,NA,NA,NA,,Sciensano,Brussels,,1050,Belgium,1
NCT04366206,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-19,NA,NA,2020-04-27,2020-04-27,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"March 14, 2020",Actual,2020-03-14,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"July 31, 2020",Anticipated,2020-07-31,14 Weeks,Observational [Patient Registry],NA,,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Recruiting,NA,NA,143,Anticipated,Centre Hospitalier Intercommunal Robert Ballanger,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-04-30T09:07:50Z,2020-04-30T09:07:50Z,NA,NA,NA,NA,Recruiting|Not yet recruiting,Centre Hospitalier Intercommunal Robert Ballanger|Groupe Hospitalier Pitie Salpetriere,Aulnay-sous-Bois|Paris,|,93600|75013,France|France,2
NCT04357639,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-22,2020-04-20,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 30, 2020",Anticipated,2020-04-30,April 2020,2020-04-30,"October 31, 2020",Anticipated,2020-10-31,"May 31, 2020",Anticipated,2020-05-31,6 Months,Observational [Patient Registry],NA,,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Prospective Description Study of the Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19,Not yet recruiting,NA,NA,794,Anticipated,Centre Hospitalier Intercommunal Creteil,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:13:02Z,2020-04-30T09:13:02Z,Other,No intervention,No intervention: Usual care for nasopharyngeal sampling and blood sampling for COVID-19 detection,1,||||,CHI CrÃ©teil|CHU Henri Mondor|Centre hospitalier de Melun (GHSIF)|HÃ´pital universitaire de HÃ´tel Dieu|CHI Villeneuve St Georges,CrÃ©teil|CrÃ©teil|Melun|Paris|Villeneuve-Saint-Georges,||||,94000|94010|77000|75004|94190,France|France|France|France|France,5
NCT04359927,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-21,NA,NA,2020-04-23,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-27,Actual,"April 20, 2020",Actual,2020-04-20,April 2020,2020-04-30,"August 31, 2025",Anticipated,2025-08-31,"August 31, 2021",Anticipated,2021-08-31,1 Year,Observational [Patient Registry],CV-COVID-19,,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Long-term Effects of Coronavirus 2019 Disease on the Cardiovascular System in Patients Who Have Undergone a Diagnostic Nasopharyngeal Swab for SARS-CoV-2. CV COVID-19 Registry,Recruiting,NA,NA,10000,Anticipated,Hospital Clinic of Barcelona,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Will be made available upon request.,2020-04-30T09:11:42Z,2020-04-30T09:11:42Z,NA,NA,NA,NA,Recruiting,Hospital ClÃ­nic of Barcelona,Barcelona,Catalonia,08036,Spain,1
NCT04359602,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-21,NA,NA,2020-04-23,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-27,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,"April 20, 2042",Anticipated,2042-04-20,"April 20, 2022",Anticipated,2022-04-20,20 Years,Observational [Patient Registry],NA,,COVID-19 Recovered Volunteer Research Participant Pool Registry,COVID-19 Recovered Volunteer Research Participant Pool Registry,Recruiting,NA,NA,10000,Anticipated,"University of California, Los Angeles",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-04-30T09:11:53Z,2020-04-30T09:11:53Z,NA,NA,NA,NA,Recruiting,Ronald Reagan UCLA Medical Center,Los Angeles,California,90095,United States,1
NCT04361591,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-22,NA,NA,2020-04-22,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"March 1, 2020",Actual,2020-03-01,March 2020,2020-03-31,March 2021,Anticipated,2021-03-31,"March 1, 2021",Anticipated,2021-03-01,2 Years,Observational [Patient Registry],COVID19-SETH,,COVID-19 in Liver Transplant Recipients,COVID-19 in Liver Transplant Recipients in Spain: a Nationwide Prospective Study,Recruiting,NA,NA,200,Anticipated,Hospital Clinic of Barcelona,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:10:42Z,2020-04-30T09:10:42Z,Other,Observational only,Observational Study,1,Recruiting,SETH-affiliated Liver Transplant Programs in Spain,Barcelona,,,Spain,1
NCT04361500,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-22,NA,NA,2020-04-22,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,"October 1, 2021",Anticipated,2021-10-01,"October 1, 2020",Anticipated,2020-10-01,30 Days,Observational [Patient Registry],COSA,,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Registry for the Evaluation of Safety and Effectiveness of the Seraph 100 Microbind Affinity Blood Filter in the Therapy of COVID-19 Patients (COSA),Recruiting,NA,NA,100,Anticipated,Hannover Medical School,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:10:46Z,2020-04-30T09:10:46Z,Device,Seraph 100,Seraph 100 therapy during a COVID-19 infection,1,Recruiting|Recruiting,Academic Teaching Hospital Brunswick|Hannover Medical School,Brunswick|Hannover,Lower Saxony|,|,Germany|Germany,2
NCT04366986,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-23,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"May 1, 2020",Anticipated,2020-05-01,April 2020,2020-04-30,"April 30, 2024",Anticipated,2024-04-30,"April 30, 2024",Anticipated,2024-04-30,1 Year,Observational [Patient Registry],IRCEP,,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,International Registry of Coronavirus Exposure in Pregnancy (IRCEP),Not yet recruiting,NA,NA,25000,Anticipated,Pregistry,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:07:22Z,2020-04-30T09:07:22Z,Other|Other,Tested for SARS-CoV-2 (regardless of the result)|Clinical diagnosis of COVID-19 by a health care professional,This is an observational study with no intervention|This is an observational study with no intervention,2,,Pregistry,Los Angeles,California,90045,United States,1
NCT04364984,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-23,NA,NA,2020-04-25,2020-04-25,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-25,2020-04-28,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"August 1, 2021",Anticipated,2021-08-01,"April 1, 2021",Anticipated,2021-04-01,4 Weeks,Observational [Patient Registry],BIRCOV,,"ARB, ACEi, DRi in COVID-19","ARB, ACEi, DRi Usage in COVID-19",Recruiting,NA,NA,10,Anticipated,Medical Practice Prof D. Ivanov,,NA,3,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:08:38Z,2020-04-30T09:08:38Z,Drug,Angiotensin converting enzyme inhibitor,routine drug intake,1,Recruiting,Medical Practice Prof D.Ivanov,Kiev,Please Select,01014,Ukraine,1
NCT04363632,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-23,NA,NA,2020-04-27,2020-04-23,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 2, 2020",Actual,2020-04-02,April 2020,2020-04-30,June 2020,Anticipated,2020-06-30,June 2020,Anticipated,2020-06-30,2 Months,Observational [Patient Registry],ONCOVID-19,,Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,Recruiting,NA,NA,150,Anticipated,Centre Leon Berard,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:09:28Z,2020-04-30T09:09:28Z,NA,NA,NA,NA,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,Institut BergoniÃ©|Centre FranÃ§ois Baclesse|Centre Hospitalier MÃ©tropole Savoie|Centre Jean Perrin|Centre Georges FranÃ§ois Leclerc|Centre Oscar Lambret|Centre Leon Berard|CH Annecy-Genevois|Institut de CancÃ©rologie de Montpellier|Groupement Hospitalier Porte de Provence|Centre Antoine Lacassagne|Centre Hospitalier Lyon-Sud|Institut Jean Godinot|Centre Henri Becquerel|Institut de CancÃ©rologie de l'Ouest|Institut de cancÃ©rologie Strasbourg Europe (ICANS)|Institut Universitaire du Cancer de Toulouse - IUCT Oncopole|CH Valence,Bordeaux|Caen|ChambÃ©ry|Clermont-Ferrand|Dijon|Lille|Lyon|Metz-Tessy|Montpellier|MontÃ©limar|Nice|Pierre-BÃ©nite|Reims|Rouen|Saint-Herblain|Strasbourg|Toulouse|Valence,|||||||||||||||||,|14076|73011|63011|21079|59020|69373|74370|34298|26216||69495|51726|76038|44805|67033|31059|,France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France,18
NCT04361981,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-23,NA,NA,2020-04-24,2020-04-23,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-24,2020-04-27,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"August 31, 2020",Anticipated,2020-08-31,6 Months,Observational [Patient Registry],TVP-COVID-RIV,,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,National Cohort Study to Assess the Influence of COVID-19 Infection in Thromboembolic Venous Disease:,Not yet recruiting,NA,NA,50,Anticipated,Sociedad Espanola de Angiologia y Cirugia Vascular,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:10:26Z,2020-04-30T09:10:26Z,Other,Deep Venous Disease Diagnostic,Clinical and/or echographic diagnosis of Deep Venous Disease in a patient with COVID-19 infection,1,,Red de Investigacion Vascular (SEACV),Madrid,,28004,Spain,1
NCT04365322,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-25,NA,NA,2020-04-27,2020-04-25,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 20, 2020",Actual,2020-04-20,April 2020,2020-04-30,"April 20, 2025",Anticipated,2025-04-20,"June 1, 2020",Anticipated,2020-06-01,5 Years,Observational [Patient Registry],COV-CREM,,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Ã‰tude Des rÃ©ponses Immunitaires Lymphocytaires spÃ©cifiques Chez Des Patients infectÃ©s Par le Virus SARS-CoV-2 : CaractÃ©ristiques Des RÃ©ponses Effectrices et MÃ©moires,Recruiting,NA,NA,60,Anticipated,Centre Hospitalier Universitaire de Besancon,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:08:25Z,2020-04-30T09:08:25Z,Other,Additional biological samples,Peripheral Blood Mononuclear Cell (PBMC) and plasma will be collected.,1,Recruiting,CHU Jean Minjoz,BesanÃ§on,,25030,France,1
NCT04368234,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-27,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"May 5, 2020",Anticipated,2020-05-05,April 2020,2020-04-30,"April 30, 2025",Anticipated,2025-04-30,"April 30, 2025",Anticipated,2025-04-30,5 Years,Observational [Patient Registry],NA,,Duke COVID-19 Shared Data and Specimen Repository,Duke Shared Data and Specimen Repository Regarding COVID-19 Patients,Recruiting,NA,NA,100000,Anticipated,Duke University,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Biological specimens may include, but are not limited to, tissue, blood, urine, sputum,
      feces, genetic, and/or cell samples.
    ",NA,NA,NA,No,NA,2020-04-30T09:06:38Z,2020-04-30T09:06:38Z,NA,NA,NA,NA,Recruiting,Duke University Medical Center,Durham,North Carolina,27710,United States,1
NCT04368143,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-27,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"June 30, 2020",Anticipated,2020-06-30,7 Days,Observational [Patient Registry],IMSEQ,,COVID-19 Immune Repertoire Sequencing,COVID-19 Immune Repertoire Sequencing,Recruiting,NA,NA,100,Anticipated,"Institute of Tropical Medicine, Belgium",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:06:41Z,2020-04-30T09:06:41Z,NA,NA,NA,NA,Recruiting,Universitairy hospital of Antwerp,Antwerp,,,Belgium,1
NCT04367714,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-27,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"March 15, 2020",Actual,2020-03-15,April 2020,2020-04-30,"December 1, 2021",Anticipated,2021-12-01,"December 1, 2020",Anticipated,2020-12-01,9 Months,Observational [Patient Registry],COVCKD,,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,Antistof Respons Mod SARS-CoV-2 Hos Dialysepatienter i Forbindelse Med COVID-19,Recruiting,NA,NA,300,Anticipated,Region MidtJylland Denmark,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Samples for determination of antibodies, cytokines, RNA and DNA
    ",NA,NA,NA,No,NA,2020-04-30T09:06:57Z,2020-04-30T09:06:57Z,NA,NA,NA,NA,Recruiting,Godstrup Hospital,Herning,,7400,Denmark,1
NCT04368065,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-28,NA,NA,2020-04-28,2020-04-28,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Estimate,"April 2, 2020",Actual,2020-04-02,April 2020,2020-04-30,"June 1, 2022",Anticipated,2022-06-01,"December 31, 2021",Anticipated,2021-12-31,3 Months,Observational [Patient Registry],NA,,Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,Recruiting,NA,NA,100000,Anticipated,Iqvia Pty Ltd,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,Data will be available during conduct of the study and two years following study completion.,Qualified researchers that have undergone a review process may submit requests to the IQVIA Registry Data Governance Committee (DGC) requesting approval and access for specific research purposes.,NA,Yes,"It is anticipated that external researchers may want to leverage these data for public health and life sciences research. The intent is to provide limited data access to qualified researchers for research that has gone through a review process. Per legal requirements, the individual data from this registry may not be transported outside of the IQVIA secured server environment. However, researchers may submit requests to the IQVIA CARE Data Governance Committee (DGC) requesting approval and access for specific research purposes.",2020-04-30T09:06:45Z,2020-04-30T09:06:45Z,NA,NA,NA,NA,Recruiting,IQVIA,Cambridge,Massachusetts,02139,United States,1
NCT04367350,"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-28,NA,NA,2020-04-28,2020-04-28,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Estimate,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"March 31, 2022",Anticipated,2022-03-31,"March 31, 2021",Anticipated,2021-03-31,24 Months,Observational [Patient Registry],NA,,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,Recruiting,NA,NA,500,Anticipated,University Hospital Tuebingen,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:07:09Z,2020-04-30T09:07:09Z,Diagnostic Test|Diagnostic Test,laboratory biomarkers|muscle ultrasound,"creatine kinase, troponin, urine myoglobin, and autoimmune antibodies|Muscle echogenicity in the upper and lower extremities, the accessory respiratory serratus anterior muscle, and abdominal wall according to qualitative ultrasound assessment (Heckmatt score)",2,Recruiting,University Hospital Tuebingen,Tuebingen,,72076,Germany,1
